A Double-Blind, Placebo-Controlled, Dose-Finding, Phase II Study To Assess the Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Ankara (MVA) Smallpox Vacine in Adults With and Without Previous Smallpox Vaccination

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/05 → 6/30/10

Funding

  • Acambis Inc: $802,093.00